These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26751422)

  • 1. Restenosis after coronary spasm in a bioresorbable vascular scaffold.
    Dalos D; Vertesich M; Jakowitsch J; Lang IM
    Coron Artery Dis; 2016 Mar; 27(2):159-61. PubMed ID: 26751422
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of bioresorbable vascular scaffold in in-stent restenosis previously exposed to vascular brachytherapy.
    Wong KL; Fan KY; Jim MH
    Int J Cardiol; 2015 Feb; 181():1-2. PubMed ID: 25473779
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary spasm revascularized with a bioresorbable vascular scaffold.
    Bil J; Pawlowski T; Gil RJ
    Coron Artery Dis; 2015 Nov; 26(7):634-6. PubMed ID: 26267749
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent Angina Due to Epicardial Coronary Artery Spasm After Successful Bioresorbable Vascular Scaffold Implantation.
    Lindemann H; Sechtem U; Ong P
    Circ J; 2015; 79(8):1853-4. PubMed ID: 25947090
    [No Abstract]   [Full Text] [Related]  

  • 5. Optical Coherence Tomography Image of Coronary Spasm in a Bioresorbable Vascular Scaffold.
    Roa-Garrido J; Gomez-Menchero AE; El Amrawy AM; Cardenal-Piris R; Camacho-Freire S; Diaz-Fernandez JF
    Can J Cardiol; 2018 Mar; 34(3):343.e9-343.e10. PubMed ID: 29395707
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioresorbable vascular scaffolds: design, clinical trials, and current applications.
    Devito F; Zito A; Dachille A; Carbonara R; Giardinelli F; Bulzis G; Navarese EP; Scicchitano P; Gaglione A; Masi F; Ciccone MM
    Coron Artery Dis; 2016 Mar; 27(2):151-8. PubMed ID: 26717005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds.
    Ohno Y; Mangiameli A; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e11-2. PubMed ID: 25499307
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired coronary artery aneurysm following treatment with bioresorbable vascular scaffolds.
    O'Gallagher K; Nerla R; Hill J; Byrne J
    EuroIntervention; 2016 Oct; 12(9):1174. PubMed ID: 27753602
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of bioresorbable scaffold failure.
    Felix C; Everaert B; Jepson N; Tamburino C; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V175-80. PubMed ID: 25983160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 12. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762
    [No Abstract]   [Full Text] [Related]  

  • 13. Bailout left main bioresorbable vascular scaffolding for the treatment of iatrogenic coronary dissection induced by guiding catheter and sticky ABSORB bioresorbable vascular scaffold balloon.
    Yew KL
    Int J Cardiol; 2015; 187():527-9. PubMed ID: 25846666
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioresorbable vascular scaffold implantation for treatment of recurrent in-stent restenosis: insights from optical coherence tomography.
    Camuglia AC; Lavi S
    Int J Cardiol; 2014 Mar; 172(1):238-9. PubMed ID: 24447733
    [No Abstract]   [Full Text] [Related]  

  • 15. Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.
    Longo G; Granata F; Capodanno D; Ohno Y; Tamburino CI; Capranzano P; La Manna A; Francaviglia B; Gargiulo G; Tamburino C
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1150-61. PubMed ID: 25573598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 17. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioresorbable scaffold failure for recurrent restenosis at multi-layered stent fracture.
    Tanaka A; Jabbour RJ; Kawamoto H; Latib A; Colombo A
    Int J Cardiol; 2016 Jul; 214():360-1. PubMed ID: 27085648
    [No Abstract]   [Full Text] [Related]  

  • 19. Restored Physiological Vasomotion Imitating Intrascaffold Restenosis 3 Years After Bioresorbable Scaffold Implantation.
    Ancona MB; Tanaka A; Latib A; Jabbour RJ; Kawamoto H; Regazzoli D; Mangieri A; Colombo A
    Can J Cardiol; 2016 Dec; 32(12):1574.e9-1574.e10. PubMed ID: 27211844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.